Recordati Competitors and Similar CompaniesClear all

Recordati's competitors and similar companies include Pharmstandard, Turning Point Therapeutics and Debiopharm.

	Recordati Recordati Industria Chimica e Farmaceutica is a company that specializes in the manufacturing and marketing of pharmaceutical products.	Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.	Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.	Debiopharm Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
Founding Date	Founding Date 1926	Founding Date 2003	Founding Date 2013	Founding Date 1979
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Private
Tags	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma
Locations	Locations Milano, IT HQ Campoverde, IT	Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Tomsk, RU Ufa, RU	Locations San Diego, US HQ	Locations Lausanne, CH HQ Oss, NL
Employees	Employees 4,450	Employees 1,15526% decrease	Employees 529% decrease	Employees 502
Financial
Revenue (est.)	Revenue (est.) €2.1b (FY, 2023)	Revenue (est.) ₽142.9b (FY, 2023)	Revenue (est.) $30.8m (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods €459.3m (FY, 2023)	Cost of goods ₽109.3b (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit €1.6b (FY, 2023)	Gross profit ₽33.6b (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income €389.2m (FY, 2023)	Net income ₽23.3b (FY, 2023)	Net income ($236.6m) (FY, 2021)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 144.4m	Total funding raised $ 2.1m